Skip to main content
. 2019 Dec;14(2):84–90. doi: 10.2174/1574884713666181112125714

Table 1. Studies involving multiple drug intolerance syndrome (MDIS) patients.

Author/
Year of
Publication
Study Design Place of Study Criteria for MDIS Total
Number of Patients Studied
Type of Studied
Population
No. of MDIS Patients
Reported
[Number (%)]
Drug Allergy
Work-up
Drugs
Involved
Antoniou
et al., 2016 [10]
Retrospective analysis UK Documented history
(at referral or new patient visit) of intolerance to at least three unrelated classes of antihypertensive
786 Adult hypertensive patients 79 (10.05%) NR Antihyper-tensives
Asero
et al., 2002 [8]
Prospective study Italy Patients with a history of MNS 36 Adult patients
with multiple intolerances to NSAIDs
22 (NR) Autologous
serum skin test (ASST)
NSAIDs
Blumenthal
et al., 2018 [13]
Retrospective record based study USA Intolerances to ≥3 drug classes 746,888 Adult patients with documented drug allergy 47,634 (6.4%) NR Multiple drug class
De Pasquale
et al., 2012 [15]
Prospective study Italy DHR to ≥3 unrelated drugs on 3 different occasion with negative allergy test 30 Adult female MDIS patients 30 (NR) Skin test, patch test, IgE titers Multiple drug class
Macy
et al., 2012 [4]
Retrospective record based study USA Intolerance to 3 or more unrelated medications 2,375,424 Patients with documented drug allergy 49,582 (2.1%) NR Multiple drug class
Okeahialam
et al., 2017 [12]
Retrospective record based study Nigeria Patients intolerant of three or more drugs with no clear
immunological mechanism
489 Adult hypertensive patients attending follow up for BP control 15 (3.06%) NR Anti-
hypertensives
Omer
et al., 2014 [11]
Retrospective record based study UK Adverse drug reactions to three or more drugs without a known immunological mechanism 25,695 Adult patients with documented drug allergy 1,250 (4.86%) NR Multiple drug class
Patriarca
et al., 1991 [14]
Prospective study Italy DHR to ≥3 unrelated drugs on 3 different occasion with negative allergy test 20 Adult female MDIS patients 20 (NR) Skin test, patch test, IgE titers Multiple drug class
Schiavino
et al., 2007 [2]
Prospective study Italy DHR to ≥3 unrelated drugs on 3 different occasion with negative allergy test 480 Adult patients with history of adverse reactions to more than 3 drug 480 (NR) Skin test, patch test, IgE titers & serum ECP level Multiple drug class

ECP: Eosinophilic Cationic Protein; DHR: Drug Hypersensitivity Reactions; MNS: Multiple Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitivity; USA: Unites States of America; UK: United Kingdom; NR: Not reported.